These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23311607)

  • 21. Mirk/Dyrk1B in cancer.
    Friedman E
    J Cell Biochem; 2007 Oct; 102(2):274-9. PubMed ID: 17583556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid turnover of cell-cycle regulators found in Mirk/dyrk1B transfectants.
    Ewton DZ; Lee K; Deng X; Lim S; Friedman E
    Int J Cancer; 2003 Jan; 103(1):21-8. PubMed ID: 12455049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Kinase Mirk/dyrk1B: A Possible Therapeutic Target in Pancreatic Cancer.
    Friedman E
    Cancers (Basel); 2010 Jul; 2(3):1492-512. PubMed ID: 24281169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marsdenia tenacissima extract induces G0/G1 cell cycle arrest in human esophageal carcinoma cells by inhibiting mitogen-activated protein kinase (MAPK) signaling pathway.
    Fan W; Sun L; Zhou JQ; Zhang C; Qin S; Tang Y; Liu Y; Lin SS; Yuan ST
    Chin J Nat Med; 2015 Jun; 13(6):428-37. PubMed ID: 26073339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mirk/dyrk1B is a Rho-induced kinase active in skeletal muscle differentiation.
    Deng X; Ewton DZ; Pawlikowski B; Maimone M; Friedman E
    J Biol Chem; 2003 Oct; 278(42):41347-54. PubMed ID: 12902328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126.
    Gao J; Niwa K; Takemura M; Sun W; Onogi K; Wu Y; Seishima M; Mori H; Tamaya T
    Int J Oncol; 2005 Mar; 26(3):737-44. PubMed ID: 15703831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells.
    Deng X; Friedman E
    Genes Cancer; 2014 Sep; 5(9-10):337-47. PubMed ID: 25352950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel dual MEK/PDK1 inhibitor 9za retards the cell cycle at G
    Liu R; Yu Z; Chen Z; Liu D; Huang F; Li Q; Hu G; Yi X; Li X; Zhou H; Liu Z
    PeerJ; 2020; 8():e9981. PubMed ID: 33072436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flavopereirine induces cell cycle arrest and apoptosis via the AKT/p38 MAPK/ERK1/2 signaling pathway in human breast cancer cells.
    Yeh HT; Tsai YS; Chen MS; Li YZ; Lin WC; Lee YR; Tseng YS; Sheu SM
    Eur J Pharmacol; 2019 Nov; 863():172658. PubMed ID: 31518562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of long non-coding RNA MALAT1 inhibits granulosa cell proliferation in endometriosis by up-regulating P21 via activation of the ERK/MAPK pathway.
    Li Y; Liu YD; Chen SL; Chen X; Ye DS; Zhou XY; Zhe J; Zhang J
    Mol Hum Reprod; 2019 Jan; 25(1):17-29. PubMed ID: 30371869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naturally Occurring Sclareol Diterpene Augments the Chemosensitivity of Human Hela Cervical Cancer Cells by Inducing Mitochondrial Mediated Programmed Cell Death, S-Phase Cell Cycle Arrest and Targeting Mitogen-Activated Protein Kinase (MAPK)/Extracellular-Signal-Regulated Kinase (ERK) Signaling Pathway.
    Li W; Ping Z; Xuemei G; Minglian L; Hongjuan M; Yi H; Zhongxiang Z
    Med Sci Monit; 2020 Jan; 26():e920248. PubMed ID: 31935210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancer.
    Jin K; Park S; Ewton DZ; Friedman E
    Cancer Res; 2007 Aug; 67(15):7247-55. PubMed ID: 17671193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activation on proliferation and cell cycle associated genes in human colon cancer cells].
    Wang X; Lu R; Fang JY
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):982-6. PubMed ID: 17650425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serine/threonine kinase Mirk/Dyrk1B is an inhibitor of epithelial cell migration and is negatively regulated by the Met adaptor Ran-binding protein M.
    Zou Y; Lim S; Lee K; Deng X; Friedman E
    J Biol Chem; 2003 Dec; 278(49):49573-81. PubMed ID: 14500717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway.
    Lavoie JN; L'Allemain G; Brunet A; Müller R; Pouysségur J
    J Biol Chem; 1996 Aug; 271(34):20608-16. PubMed ID: 8702807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depleting Mirk Kinase Increases Cisplatin Toxicity in Ovarian Cancer Cells.
    Hu J; Friedman E
    Genes Cancer; 2010 Aug; 1(8):803-811. PubMed ID: 21113238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emodin Increases Expression of Insulin-Like Growth Factor Binding Protein 1 through Activation of MEK/ERK/AMPKα and Interaction of PPARγ and Sp1 in Lung Cancer.
    Tang Q; Wu J; Zheng F; Hann SS; Chen Y
    Cell Physiol Biochem; 2017; 41(1):339-357. PubMed ID: 28214826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
    Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
    J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A wake-up call to quiescent cancer cells - potential use of DYRK1B inhibitors in cancer therapy.
    Becker W
    FEBS J; 2018 Apr; 285(7):1203-1211. PubMed ID: 29193696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.